Sorted By:

Relevance


VIDEO: PhRMA CEO joins Fox Business anchor Neil Cavuto to discuss personal connection to value of innovation and White House meeting

PhRMA  |  Blog Post

Visit .com/?
http://catalyst.phrma.org/video-phrma-ceo-joins-fox-business-anchor-neil-cavuto-to-discuss-personal-connection-to-value-of-innovation-and-white-house-meeting

World IP Day: Celebrating the protections that allow innovation to thrive

PhRMA  |  Blog Post

This World IP Day, we hope America continues their commitment to the life sciences industry and the advancement of new treatments.
http://catalyst.phrma.org/world-ip-day-celebrating-the-protections-that-allow-innovation-to-thrive

Medicare Monday: Did You Know Four out of Five Part D Prescriptions Are Generic?

PhRMA  |  Blog Post


http://catalyst.phrma.org/medicaremonday-did-you-know-four-out-of-five-part-d-prescriptions-are-generic

Study finds actual cost of 14 new medicines is billions less than predicted

PhRMA  |  Blog Post

Read more about PhRMA’s policy solutions to deliver innovative treatments to patients here.
http://catalyst.phrma.org/study-finds-actual-cost-of-14-new-medicines-is-billions-less-than-predicted

New PhRMA report: New medicines in development for autoimmune diseases offer patients hope for brighter futures

PhRMA  |  Blog Post

View the full report here.
http://catalyst.phrma.org/new-phrma-report-new-medicines-in-development-for-autoimmune-diseases-offer-patients-hope-for-brighter-futures

Celebrating cardiovascular health on World Heart Day 2015

PhRMA  |  Blog Post

As we celebrate World Heart Day, it is important to remember the role of continued innovation in reducing the impact of heart disease and helping patients live longer, healthier lives.
http://catalyst.phrma.org/celebrating-cardiovascular-health-on-world-heart-day-2015

New report highlights more than 250 vaccines in development

PhRMA  |  Blog Post

View the full report here.
http://catalyst.phrma.org/new-report-highlights-more-than-250-therapeutic-and-preventative-vaccines-in-development

Strong R&D Investment the Best Bet to Slow Alzheimer’s Growing Threat

PhRMA  |  Blog Post

Building on these “failures,” researchers today are studying more than 80 medicines in development, to identify better treatments for patients.
http://catalyst.phrma.org/strong-rd-investment-the-best-bet-to-slow-alzheimers-growing-threat

New Hampshire

Access Better Coverage  |  From Our Network

Enforcing non-discrimination requirements, which apply to benefit design and provider networks;  Establishing stronger rules regarding exceptions and appeals processes, which help enrollees get the medicines and care their doctors recommend; and   Enhancing the state's marketplace website or advocating for a Healthcare.gov page that allows for easier plan comparisons, including searchable formularies and estimates of total out-of-pocket costs.
http://www.accessbettercoverage.org/states/new-hampshire

PhRMA Board of Directors Elects New Officers, Welcomes New Member Company

PhRMA  |  Press Release

“Helping patients and addressing the burden of disease is what drives the men and women of this industry every single day,” said Bradway.
http://www.phrma.org/press-release/phrma-board-of-directors-elects-new-officers-welcomes-new-member-company

New report highlights more than 250 vaccines in development

PhRMA  |  Blog Post

View the full report here.
http://catalyst.phrma.org/new-report-highlights-more-than-250-vaccines-in-development

Paul A. Aines Named PhRMA Executive Vice President and Chief Financial Officer; Del Persinger to Retire

PhRMA  |  Press Release

Connect with PhRMA For information on how innovative medicines save lives, please visit: www.PhRMA.orgwww.FromHopetoCures.orgwww.Facebook.com/PhRMAwww.Twitter.com/PhRMA
http://www.phrma.org/press-release/paul-a-aines-named-phrma-executive-vice-president-and-chief-financial-officer-del-persinger-to-retire

PhRMA Foundation Launches New Web Platform

PhRMA  |  Blog Post

Later this year, we’ll be launching educational modules for health care professionals developed in partnership with the National Institutes of Health (NIH) and the American Society of Clinical Pharmacology and Therapeutics (ASCPT).
http://catalyst.phrma.org/phrma-foundation-launches-new-web-platform

Rep. Clyburn among speakers at “Research in Your Backyard” press conference

PhRMA  |  Press Release

“Clinical trials provide an important message of hope for patients who seek new treatment for unmet medical needs.
http://www.phrma.org/press-release/rep-clyburn-among-speakers-at-research-in-your-backyard-press-conference

Medicamentos en Desarrollo para la Diabetes

PhRMA  |  Report

Para muchos pacientes, un diagnóstico de diabetes afecta casi todos los aspectos de, su vida, incluidas las preocupaciones de una dieta especial y otros cambios en el estilo de vida, así como los medicamentos que a diario deben tomar para manejar los niveles de glucosa en la sangre.
http://www.phrma.org/report/medicamentos-en-desarrollo-para-la-diabetes

New Medicine Approvals 2015 Report

PhRMA  |  Report

The new medicines approved by the FDA in 2015 demonstrate the tireless work of America’s biopharmaceutical researchers and scientists to deliver on the promise of science.
http://www.phrma.org/report/new-medicine-approvals-2015-report

ICYMI – IMS Institute – Branded net medicine price increases “lowest in past five years”

PhRMA  |  Blog Post

Learn more at www.phrma.org/cost.
http://catalyst.phrma.org/icymi-ims-institute-branded-net-medicine-price-increases-lowest-in-past-five-years

#RarePOV Conversation Generates Strong Enthusiasm for Rare Disease Day on February 28th

PhRMA  |  Blog Post

Defining Success When I asked what makes rare disease advocacy efforts successful, @CurityMD captured the sentiment of the chat by stating it is “passion, dedication & an incredible network of friends and family; community is key.
http://catalyst.phrma.org/rarepov-conversation-generates-strong-enthusiasm-for-rare-disease-day-on-february-28th

New Report: Nearly 4.5 Million U.S. Jobs and $1.2 Trillion Economic Output Supported by Biopharmaceutical Sector in 2014

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than half a trillion dollars in the search for new treatments and cures, including an estimated $58.8 billion in 2015 alone.
http://www.phrma.org/press-release/new-report-nearly-4-5-million-u-s-jobs-and-1-2-trillion-economic-output-supported-by-biopharmaceutical-sector-in-2014

ICYMI: Report highlights overall decrease in cancer death rates

PhRMA  |  Blog Post

Read more about the work being done by America’s biopharmaceutical companies in cancer treatment and about the last decade of innovation in cancer.
http://catalyst.phrma.org/icymi-report-highlights-overall-decrease-in-cancer-death-rates

New Study: Substantial rebates negotiated in Medicare Part D

PhRMA  |  Blog Post

This report is further evidence of the robust negotiating power of Part D plans and how they secure rebates and discounts to keep costs low for beneficiaries and taxpayers.
http://catalyst.phrma.org/new-study-substantial-rebates-negotiated-in-medicare-part-d

Welcome to the new PhRMA.org

PhRMA  |  Blog Post

Explore PhRMA’s new digital home at www.phrma.org.
http://catalyst.phrma.org/welcome-to-the-new-phrma.org

Cost of mental illness underscores need for new treatments

PhRMA  |  Blog Post

Learn more in the 2016 “Medicines in Development for Mental Illnesses” report, and see the full list of medicines currently in development to treat mental illnesses.
http://catalyst.phrma.org/cost-of-mental-illness-underscores-need-for-new-treatments

New Questions About Why More Women Than Men Have Alzheimer's

From Hope To Cures  |  From Our Network

But it wasn't until after her own diagnosis a few years ago that Shives looked up the gender statistics.
http://www.fromhopetocures.org/new-questions-about-why-more-women-than-men-have-alzheimers

PhRMA Convenes Stakeholders to Discuss Value Assessments and New Ways to Pay for Medicines

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than half a trillion dollars in the search for new treatments and cures, including an estimated $58.8 billion in 2015 alone.
http://www.phrma.org

You have reviewed the first 100 results out of 1864. Each page contains 25 results. You're on page 4.

prev 1 2 3 4 5 6 next